Le Lézard
Classified in: Health
Subject: MAT

MTL CANNABIS CORP. COMMENCES TRADING ON CSE UNDER THE SYMBOL MTLC


TORONTO, Aug. 17, 2023 /CNW/ - MTL Cannabis Corp. (CSE: MTLC) ("MTL Cannabis" or the "Company"), is pleased to announce that the Company has received final approval to list its common shares on the Canadian Securities Exchange (the "CSE") under the trading symbol "MTLC" and to commence trading at the opening of Monday, August 21, 2023.

"Successfully completing a listing on the CSE is a significant milestone and the last step in the business combination between Canada House Cannabis Group Inc. and Montréal Medical Cannabis Inc. Our team has put forward an incredible effort to get us to this point and we are incredibly excited to continue to integrate the businesses and position the Company as a top performer in the Canadian cannabis industry." - Michael Perron, CEO of MTL Cannabis.

About MTL Cannabis

MTL Cannabis is the parent company of Montréal Medical Cannabis Inc., a licensed producer operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., with clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.

As a flower-first company built for the modern street, MTL Cannabis uses proprietary hydroponic growing methodologies supported by handcrafted techniques to produce products that are truly craft for the masses. MTL Cannabis focuses on craft quality cannabis products, including lines of dried flower, pre-rolls and hash marketed under the "MTL Cannabis", "Low Key by MTL" and "R'belle" brands for the Canadian market through nine distribution arrangements with various provincial cannabis distributors. MTL Cannabis has also developed a number of export channels for bulk and unbranded GACP quality cannabis.

It is MTL Cannabis' goal for Abba Medix Corp. to become the leading distributor of medical cannabis in Canada and for Canada House Clinics to be the leading Canadian provider of medical cannabis clinic services. Please visit http://www.mtlcannabis.ca/, https://isocanmed.com/, https://abbamedix.com/, www.canadahouse.ca, or the Company's public filings at www.sedarplus.ca.

Cautionary Statement Regarding Forward-Looking Information.

This press release contains forward- looking statements, including statements that relate to, among other things, the Company's clinic, production and technology businesses, its future plans, the Company's markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely", "possible", "expect", "intend", "estimate", "anticipate", "believe", "plan", "objective" and "continue" (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, among other things, the listing of the Shares on the CSE, the regulations related to cannabis use under the Cannabis Act (Canada); Company liquidity and capital resources, including the availability of additional capital resources to fund its activities; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; and the ability to execute strategic plans. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company's Listing Statement dated August 14, 2023 and its most recent annual and interim Management's Discussion and Analysis under "Risk and Uncertainties" as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

SOURCE MTL Cannabis Corp.


These press releases may also interest you

at 04:04
Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration...

at 03:47
The 90th China International Medical Equipment Fair (CMEF) has successfully kicked off in Shenzhen, running from October 12-15. This year's event spans nearly 200,000 square meters and hosts nearly 4,000 exhibitors with an audience surpassing 200,000...

at 02:00
Today is World Thrombosis Day, a global campaign established by the International Society on Thrombosis and Haemostasis (ISTH) to engage the general public, healthcare providers and policymakers in spreading awareness of the signs, symptoms, risk...

12 oct 2024
Product: Tagliatelle Seasoned White Chicken & Mushroom Sauce Issue: Food - Microbial contamination - Listeria Distribution:National See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

12 oct 2024
Product: Filet Royal Smoked Atlantic Salmon Issue:Food - Microbial contamination - Listeria Distribution:Quebec See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

12 oct 2024
Aileron Therapeutics, Inc. ("Aileron") (NASDAQ:...



News published on and distributed by: